GS
SCLN

Gagnon Securities’s Sciclone Pharmaceuticals Inc SCLN Stock Holding History

Gagnon Securities’s Portfolio SCLN Stock Details SCLN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2014
Q3 		– Sell
-63,905
Closed -$336K – 106
2014
Q2 		$336K Sell
63,905
-15,337
-19% -$74.6K 0.11% 68
2014
Q1 		$361K Buy
79,242
+1,245
+2% +$6.01K 0.11% 69
2013
Q4 		$393K Buy
77,997
+300
+0.4% +$1.44K 0.12% 61
2013
Q3 		$394K Buy
+77,697
New +$433K 0.12% 58

Other funds holding SCLN

Franklin Resources
Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
QBFM
QS Batterymarch Financial Management New York $3.78B AUM 22.02% 1-Year Est. Return

Gagnon Securities's SCLN Position: Q3 2014 in Review

Gagnon Securities sold out of Sciclone Pharmaceuticals Inc (SCLN) in Q3 2014, closing a stake of 63,905 shares — an estimated $336K sold.

Gagnon Securities first reported a position in SCLN in Q3 2013 and held it in 4 quarters. The position peaked at $394K in Q3 2013. 116 funds tracked by Wall St. Rank hold SCLN as of Q3 2014.

  • Gagnon Securities reported no remaining Sciclone Pharmaceuticals Inc position as of Q3 2014 after selling out during the quarter.
  • Gagnon Securities sold 63,905 Sciclone Pharmaceuticals Inc shares in Q3 2014, an estimated $336K.
  • Gagnon Securities first reported a position in Sciclone Pharmaceuticals Inc in Q3 2013 and held it in 4 quarters.
  • Gagnon Securities's Sciclone Pharmaceuticals Inc position peaked at $394K in Q3 2013.
  • 116 funds tracked by Wall St. Rank held Sciclone Pharmaceuticals Inc as of Q3 2014.

Based on Gagnon Securities's 13F filing for Q3 2014, filed 15 Oct 2014.